Physician profile
Phillip Stack
NPI 1770678591
$2,815.01
in general payments reported to CMS, 2019-2025
18 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $107 · 2021: $433 · 2022: $499 · 2023: $626 · 2024: $461 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $776.45 | 2021-2025 | Stelara, Tremfya |
| Abbvie INC. | $762.12 | 2019-2025 | Linzess, Rinvoq, Creon |
| Pfizer INC. | $197.32 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $173.58 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.57 | 2021-2023 | Trulance |
| Medtronic, INC. | $147.51 | 2022-2023 | Endoflip |
| Takeda Pharmaceuticals U.S.A., INC. | $128.32 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $82.49 | 2021-2024 | Dificid |
| Phathom Pharmaceuticals, INC. | $82.42 | 2024-2025 | Voquezna |
| Celgene Corporation | $66.96 | 2021-2024 | Zeposia |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Ironwood Pharmaceuticals, INC | $45.53 | 2019-2022 | |
| Gilead Sciences, INC. | $41.20 | 2022-2024 | |
| Genzyme Corporation | $39.14 | 2024 | |
| Intercept Pharmaceuticals, INC. | $23.99 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $18.85 | 2024 | Endoclot Phs |
| Fresenius Kabi USA, LLC | $14.82 | 2023 | Idacio |
| Allergan, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Stack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.